These results, mirroring most of the alterations in signaling molecules described in CK2βKO murine B cells, suggest that CK2 is essential in promoting and sustaining the activation of BCR signaling molecules also in DLBCL cells. Here, BCR is linked to diffuse large B-cell lymphoma.